Vaximm Appoints Sébastien Wieckowski as Chief Scientific Officer.

Vaximm AG, a subsidiary of OSR Holdings, has appointed Sébastien Wieckowski, PhD, as Chief Scientific Officer. Dr. Wieckowski brings expertise in immunology and data science, and will focus on integrating analytical workflows and data-driven strategies to accelerate discovery and optimize platform performance. His appointment is expected to strengthen Vaximm's leadership and advance its oral T-cell immunotherapies for cancer.